126 related articles for article (PubMed ID: 1380608)
21. Enhanced natriuretic response to neutral endopeptidase inhibition in heart-transplant recipients.
Geny B; Hardy H; Lonsdorfer J; Eisenmann B; Haberey P; Piquard F
Hypertension; 1999 Apr; 33(4):969-74. PubMed ID: 10205232
[TBL] [Abstract][Full Text] [Related]
22. Potentiation of natriuretic peptides by neutral endopeptidase inhibitors.
Seymour AA; Abboa-Offei BE; Smith PL; Mathers PD; Asaad MM; Rogers WL
Clin Exp Pharmacol Physiol; 1995 Jan; 22(1):63-9. PubMed ID: 7768036
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of SQ 28,603, an inhibitor of neutral endopeptidase, in conscious monkeys.
Seymour AA; Abboa-Offei B; Asaad MM; Rogers WL
Can J Physiol Pharmacol; 1991 Oct; 69(10):1609-17. PubMed ID: 1663819
[TBL] [Abstract][Full Text] [Related]
24. The role of neutral endopeptidase in dogs with evolving congestive heart failure.
Margulies KB; Barclay PL; Burnett JC
Circulation; 1995 Apr; 91(7):2036-42. PubMed ID: 7895362
[TBL] [Abstract][Full Text] [Related]
25. Systemic hemodynamics, renal function and hormonal levels during inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in conscious dogs with pacing-induced heart failure.
Seymour AA; Asaad MM; Lanoce VM; Langenbacher KM; Fennell SA; Rogers WL
J Pharmacol Exp Ther; 1993 Aug; 266(2):872-83. PubMed ID: 8394922
[TBL] [Abstract][Full Text] [Related]
26. Combined endopeptidase inhibition and adrenomedullin in sheep with experimental heart failure.
Rademaker MT; Charles CJ; Cooper GJ; Coy DH; Espiner EA; Lewis LK; Nicholls MG; Richards AM
Hypertension; 2002 Jan; 39(1):93-8. PubMed ID: 11799085
[TBL] [Abstract][Full Text] [Related]
27. Enhanced natriuretic response to neutral endopeptidase inhibition in patients with moderate chronic renal failure.
Lipkin GW; Dawnay AB; Harwood SM; Cattell WR; Raine AE
Kidney Int; 1997 Sep; 52(3):792-801. PubMed ID: 9291201
[TBL] [Abstract][Full Text] [Related]
28. Interaction of a neutral endopeptidase inhibitor with an ANP-C receptor ligand in anesthetized dogs.
Wegner M; Stasch JP; Hirth-Dietrich C; Dressel J; Voges KP; Kazda S
Clin Exp Hypertens; 1995 Aug; 17(6):861-76. PubMed ID: 7581258
[TBL] [Abstract][Full Text] [Related]
29. Beneficial renal and hemodynamic effects of omapatrilat in mild and severe heart failure.
Troughton RW; Rademaker MT; Powell JD; Yandle TG; Espiner EA; Frampton CM; Nicholls MG; Richards AM
Hypertension; 2000 Oct; 36(4):523-30. PubMed ID: 11040230
[TBL] [Abstract][Full Text] [Related]
30. Neutral endopeptidase inhibition attenuates development of hypoxic pulmonary hypertension in rats.
Klinger JR; Petit RD; Warburton RR; Wrenn DS; Arnal F; Hill NS
J Appl Physiol (1985); 1993 Oct; 75(4):1615-23. PubMed ID: 8282611
[TBL] [Abstract][Full Text] [Related]
31. Endopeptidase inhibition in angiotensin-induced hypertension. Effect of SCH 39370 in sheep.
Charles CJ; Espiner EA; Richards AM; Sybertz EJ
Hypertension; 1995 Jul; 26(1):89-94. PubMed ID: 7607738
[TBL] [Abstract][Full Text] [Related]
32. Hemodynamic, renal, and hormonal effects of rapid ventricular pacing in conscious dogs.
Seymour AA; Burkett DE; Asaad MM; Lanoce VM; Clemons AF; Rogers WL
Lab Anim Sci; 1994 Oct; 44(5):443-52. PubMed ID: 7844952
[TBL] [Abstract][Full Text] [Related]
33. Atrial natriuretic factor-potentiating and antihypertensive activity of SCH 34826. An orally active neutral metalloendopeptidase inhibitor.
Sybertz EJ; Chiu PJ; Vemulapalli S; Watkins R; Haslanger MF
Hypertension; 1990 Feb; 15(2):152-61. PubMed ID: 2154404
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of the metabolism of atrial natriuretic factor causes diuresis and natriuresis in chronic heart failure.
Northridge DB; Jardine AG; Findlay IN; Archibald M; Dilly SG; Dargie HJ
Am J Hypertens; 1990 Sep; 3(9):682-7. PubMed ID: 2145874
[TBL] [Abstract][Full Text] [Related]
35. Angiotensin inhibition potentiates the renal responses to neutral endopeptidase inhibition in dogs with congestive heart failure.
Margulies KB; Perrella MA; McKinley LJ; Burnett JC
J Clin Invest; 1991 Nov; 88(5):1636-42. PubMed ID: 1658047
[TBL] [Abstract][Full Text] [Related]
36. Acute reversal of cyclosporine nephrotoxicity by neutral endopeptidase inhibition in stable renal transplant recipients.
Lipkin GW; Thuraisingham R; Dawnay AB; Harwood SM; Raine AE
Transplantation; 1997 Oct; 64(7):1007-17. PubMed ID: 9381523
[TBL] [Abstract][Full Text] [Related]
37. Response to atrial natriuretic peptide, endopeptidase 24.11 inhibitor and C-ANP receptor ligand in the rat.
Wilkins MR; Settle SL; Kirk JE; Taylor SA; Moore KP; Unwin RJ
Br J Pharmacol; 1992 Sep; 107(1):50-7. PubMed ID: 1330165
[TBL] [Abstract][Full Text] [Related]
38. Brain natriuretic peptide and neutral endopeptidase inhibition in left ventricular impairment.
Lainchbury JG; Richards AM; Nicholls MG; Espiner EA; Yandle TG
J Clin Endocrinol Metab; 1999 Feb; 84(2):723-9. PubMed ID: 10022444
[TBL] [Abstract][Full Text] [Related]
39. Long-term treatment with neutral endopeptidase inhibitor improves cardiac function and reduces natriuretic peptides in rats with chronic heart failure.
Maki T; Nasa Y; Yamaguchi F; Yoshida H; Mori M; Takada T; Horikawa E; Okano K; Takeo S
Cardiovasc Res; 2001 Aug; 51(3):608-17. PubMed ID: 11476752
[TBL] [Abstract][Full Text] [Related]
40. Bioactivity of natriuretic peptide coinfusions; no evidence for unique effects of BNP in conscious sheep.
Charles CJ; Espiner EA; Nicholls MG; Rademaker MT; Richards AM
J Cardiovasc Pharmacol; 1999 Feb; 33(2):229-36. PubMed ID: 10028930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
